Metropolis Healthcare

Metropolis Healthcare is a prominent diagnostic company based in Mumbai, Maharashtra, specializing in a wide array of clinical laboratory tests. With over 4,500 types of tests available, Metropolis processes approximately 15 million tests annually, serving more than 10,000 laboratories, hospitals, nursing homes, and 200,000 doctors across India. The company is accredited by the National Accreditation Board for Testing and Calibration Laboratories and the College of American Pathologists, ensuring high standards in laboratory practices. With 34 years of experience, Metropolis has established itself as a respected multinational chain of diagnostic centers. In recent years, it has diversified its services to include Clinical Trials, Hospital Lab Management, Home Health Services, Preventive Health Check-ups, and Corporate & Wellness Solutions. The company's primary focus remains on pathology services, which is the principal activity driving its revenue.

Vijender Singh

CEO

4 past transactions

Scientific Pathology

Acquisition in 2025
Scientific Pathology Laboratories Private Limited is a healthcare company that specializes in providing diagnostic services. Their offerings include a wide range of tests and screenings, such as blood tests, urine tests, and other pathology services. They utilize modern technology and equipment to ensure accurate and timely results. The company also offers home collection services, making it convenient for patients to get their samples collected from the comfort of their homes.

Hitech Diagnostic Centre

Acquisition in 2021
Hitech Diagnostic Centre Established in 1986, runs 31 laboratories including three NABL and ICMR accredited laboratories and 68 collection centres strategically spread across the states of Tamil Nadu, Karnataka, Kerala, Andhra Pradesh, and the Union Territory of Pondicherry. Hitech is the second-largest player in Chennai behind Metropolis and is a leader in non-Chennai markets in the state of Tamil Nadu. Hitech caters to the mid-segment of the market and has a large B2C footprint. The Brand has a strong recall in the diagnostics industry in all its end markets. It has a test menu of more than 1,100 tests ranging from routine to highly impenetrable molecular & genetic assays. In FY20, 59% of the test menu was focused on blood biochemistry and endocrinology. The company's revenue for FY20 stood at Rs 83.3 crore with an EBITDA margin profile similar to Metropolis.

Shraddha Pathology Lab

Acquisition in 2020
Shraddha Pathology Laboratory is established since 2000 and has proved its quality services in field of Laboratory medicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.